Bioactive Phytophenolics of Vitex negundo Reveal Therapeutic Antifungal Potentials against Candida albicans.
10.1007/s11655-024-3913-3
- Author:
Neha JAISWAL
1
;
Awanish KUMAR
2
Author Information
1. Department of Biotechnology, National Institute of Technology, Raipur, CG, 492010, India.
2. Department of Biotechnology, National Institute of Technology, Raipur, CG, 492010, India. awanik.bt@nitrr.ac.in.
- Publication Type:Journal Article
- Keywords:
Candida albicans;
Vitex negund;
antifungal;
biotherapeutics;
phenolics
- MeSH:
Candida albicans/physiology*;
Vitex/chemistry*;
Antifungal Agents/chemistry*;
Microbial Sensitivity Tests;
Biofilms/drug effects*;
Phenols/pharmacokinetics*;
Plant Extracts/chemistry*;
Antioxidants/pharmacology*;
Phytochemicals/pharmacology*;
Humans
- From:
Chinese journal of integrative medicine
2025;31(6):541-551
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To map the potent antifungal properties of the medicinal plant Vitex negundo, in vitro and in silico studies were performed to decipher the pharmacokinetics and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of their phytoconstituents.
METHODS:With the PASS (Prediction of Activity Spectra for Substances) prediction tool, many parameters of V. negundo phenolics were examined, including drug-likeness, bioavailability, antifungal activity, and anti-biofilm activity. Moreover, ADMET parameters were also determined.
RESULTS:Eighteen phenolic compounds from V. negundo with significant antifungal activity against Candida species (human fungal pathogens) were detected. The antioxidant activity, inhibition percentage, and minimum inhibitory concentration value of V. negundo phenolic extracts indicate it as an effective antifungal agent for the treatment of candidiasis caused by the fungal pathogen Candida albicans. Many phenolic compounds showed a significantly high efficiency against Candida's planktonic cells and biofilm condition.
CONCLUSIONS:The phenolics fraction of V. negundo has potent antifungal activities, however, some more pre-clinical studies are a matter of future research to further investigate V. negundo phenolic compound as a potential new antifungal arsenal.
